Lisinopril: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Changed protection level for "Lisinopril" ([Edit=Allow only autoconfirmed users] (expires 18:44, 27 February 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 18:44, 27 February 2014 (UTC))))
No edit summary
Line 1: Line 1:
<small>'''''Synonyms / Brand Names: lisinopril, Acercomp, Inhibril, Linopril, Lisinopril Dihydrate, Lisipril, Lysinopril, Noperten, Presiten, Prinivil, Prinzide, Renacor, Sinopril, Zestril
__NOTOC__
''''' </small>
{{Lisinopril}}
{{CMG}}
{{CMG}}; {{AE}} {{AM}}


==Dosing and Administration==
'''''For patient information about Lisinopril, click [[Lisinopril (patient information)|here]].'''''
In patients with uncomplicated essential hypertension not on diuretic therapy, the recommended initial dose is 10 mg once
 
a day. Dosage should be adjusted according to blood pressure response. The usual dosage range is 20 to 40 mg per day administered in a
{{SB}} LISINOPRIL<sup>®</sup>, ACERCOMP<sup>®</sup>, INHIBRIL<sup>®</sup>, LINOPRIL<sup>®</sup>, LISINOPRIL DIHYDRATE<sup>®</sup>, LISIPRIL<sup>®</sup>, LYSINOPRIL<sup>®</sup>, NOPERTEN<sup>®</sup>, PRESITEN<sup>®</sup>, PRINIVIL<sup>®</sup>, PRINZIDE<sup>®</sup>, RENACOR<sup>®</sup>, SINOPRIL<sup>®</sup>, ZESTRIL<sup>®</sup>
single daily dose. The antihypertensive effect may diminish toward the end of the dosing interval regardless of the administered dose, but
 
most commonly with a dose of 10 mg daily.
==Overview==
Lisinopril is a drug of the angiotensin-converting enzyme (ACE) inhibitor class used primarily in treatment of [[hypertension]], [[congestive heart failure]], and heart attacks, and also in preventing renal and [[retinal complications]] of [[diabetes]]. Its indications, contraindications and side effects are as those for all ACE inhibitors.
Lisinopril was the third ACE inhibitor (after [[captopril]] and [[enalapril]]) and was introduced into therapy in the early 1990s. A number of properties distinguish it from other ACE inhibitors: It is hydrophilic, has a long half-life and tissue penetration, and is not metabolized by the liver.
 
==Category==
Antihypertensive Agents, ACE Inhibitors
 
==FDA Package Insert==
 
'''  [[Lisinopril indications and usage|Indications and Usage]]'''
'''| [[Lisinopril dosage and administration|Dosage and Administration]]'''
'''| [[Lisinopril contraindications|Contraindications]]'''
'''| [[Lisinopril warnings and precautions|Warnings and Precautions]]'''
'''| [[Lisinopril adverse reactions|Adverse Reactions]]'''
'''| [[Lisinopril drug interactions|Drug Interactions]]'''
'''| [[Lisinopril use in specific populations|Use in Specific Populations]]'''
'''| [[Lisinopril overdosage|Overdosage]]'''
'''| [[Lisinopril description|Description]]'''
'''| [[Lisinopril clinical pharmacology|Clinical Pharmacology]]'''
'''| [[Lisinopril clinical studies|Clinical Studies]]'''
'''| [[Lisinopril how supplied storage and handling|How Supplied/Storage and Handling]]'''
'''| [[Lisinopril patient counseling information|Patient Counseling Information]]'''
'''| [[Lisinopril labels and packages|Labels and Packages]]'''
 
{|
| [[File:a10.png|800px|thumb]]
|}
==References==
 
{{Reflist|2}}
 
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]


''For more information on Dosing please refer to'' [[Lisinopril instructions for administration|Instructions for Administration]]
<br>
----
<br>
<br>
<font size="4">
<font size="4">
Line 41: Line 70:
----
----
<br>
<br>
<br>
<br>
<br>
==FDA Package Insert Resources==
==FDA Package Insert Resources==
[[{{PAGENAME}} indications|Indications]]
[[{{PAGENAME}} indications|Indications]]

Revision as of 20:07, 13 February 2014


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2], Amr Marawan, M.D. [3]

Lisinopril

Lisinopril and Hydrochlorothiazide tablet

Overview

Lisinopril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.

Category

Antihypertensive Agents, Angiotensin Converting Enzyme Inhibitors. Editor-In-Chief: C. Michael Gibson, M.S., M.D. [4]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [5]

For patient information about Lisinopril, click here.

Synonyms / Brand Names: LISINOPRIL®, ACERCOMP®, INHIBRIL®, LINOPRIL®, LISINOPRIL DIHYDRATE®, LISIPRIL®, LYSINOPRIL®, NOPERTEN®, PRESITEN®, PRINIVIL®, PRINZIDE®, RENACOR®, SINOPRIL®, ZESTRIL®

Overview

Lisinopril is a drug of the angiotensin-converting enzyme (ACE) inhibitor class used primarily in treatment of hypertension, congestive heart failure, and heart attacks, and also in preventing renal and retinal complications of diabetes. Its indications, contraindications and side effects are as those for all ACE inhibitors. Lisinopril was the third ACE inhibitor (after captopril and enalapril) and was introduced into therapy in the early 1990s. A number of properties distinguish it from other ACE inhibitors: It is hydrophilic, has a long half-life and tissue penetration, and is not metabolized by the liver.

Category

Antihypertensive Agents, ACE Inhibitors

FDA Package Insert

Indications and Usage | Dosage and Administration | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

References


FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español


FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Lisinopril
Return to top

Publication Resources

Most Recent Articles on Lisinopril

Review Articles on Lisinopril

Articles on Lisinopril in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Lisinopril

Return to top

Trial Resources

Ongoing Trials with Lisinopril at Clinical Trials.gov

Trial Results with Lisinopril

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Lisinopril

Cochrane Collaboration on Lisinopril

Cost Effectiveness of Lisinopril

Return to top

Media Resources

Powerpoint Slides on Lisinopril

Images of Lisinopril

Podcasts & MP3s on Lisinopril

Videos on Lisinopril

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Lisinopril

Discussion Groups on Lisinopril

Patient Handouts on Lisinopril

Blogs on Lisinopril

Lisinopril in the News

Lisinopril in the Marketplace

Return to top

International Resources

Lisinopril en Español

Return to top

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Lisinopril&oldid=943302"